FDA Approves Cabozantinib for Adults and Paediatric Patients 12 Years of Age and Older with pNET and epNET By Ogkologos - April 18, 2025 585 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the CABINET study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR ‘Normal’ cells and ‘cancer’s surprising circular DNA’: Inside Cancer Grand Challenges... June 23, 2022 Patient-Reported Outcomes Support the Overall Benefit of Trastuzumab Deruxtecan for Patients... May 24, 2023 41-Year-Old Wrinkled Woman Who Ages 8 Times Faster Than Normal Is... March 14, 2019 NGS Is Effective in Identifying Actionable Genetic Alterations for Investigational Targeted... April 13, 2022 Load more HOT NEWS How I Found a Meaningful Career After Cancer EMA Recommends Extension of Therapeutic Indications for Daratumumab Seven Ways an Occupational Therapist Can Help Patients Recovering From Breast... First New Drug in Years Reduces Recurrence in High-risk Hormone Receptor...
